Search Results

The Berlin Heals Holding AG has developed the C-MIC device, a revolutionary and life-saving treatment for patients with heart failure.

CMIC Co., Ltd. has launched services using SUSMED, Inc.’s trial management system covering subject registration, software assignment and distribution for digital therapeutics.

CMIC HOLDINGS Co., Ltd. announced that CMIC is providing monitoring services as a CRO for “Avigan® Tablet”, a product that FUJIFILM Toyama Chemical Co., Ltd. gained approval in Japan for manufacture and sale as an influenza antiviral drug, phase III clinical trial in Japan and will support for manufacturing the product as a CDMO..

CMIC Group, a pioneer and a leading CRO in Japan, is pleased to announce that the company joined Align Clinical CRO, a life sciences industry standards group dedicated to creating open technology standards that make it easier for sponsors and contract research organizations to work together during trials.

Science 37 today announced a partnership to further decentralized clinical trials and to help speed the development of treatments.

Median Technologies, the industry-leading Imaging Phenomics Company® (Paris:ALMDT) and CMIC HOLDINGS Co., Ltd. (CMIC), a leading Contract Research Organization (CRO) with services for development, manufacturing, sales, and marketing of pharmaceutical products, today announced a collaborative agreement for comprehensive clinical trial services.